Abstract
The relationship between the development of telangiectasias and hormonal intake has not been well studied and is empirically managed by phlebologists. To understand the behavior of the international phlebologic community regarding the treatment of leg telangiectasia in patients taking oral contraceptives or receiving postmenopausal hormone replacement therapy. Simple questions concerning the causal effects of hormones, their influence on treatment, and general behavior were asked by an electronic mail questionnaire sent to 131 phlebologists in my personal database. The 61 answers received show the existence of two opposite "parties" concerning the influence of hormones on telangiectasia: cause and treatment. Opposite opinions without any scientific basis underline the ignorance surrounding a subject that concerns 50% of our patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
